Partnership Expands Capital Access to Support Development of Solar, Battery, Microgrid, and Wireless EV Charging Projects within NextNRG’s National PipelineMIAMI, June 12, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy solutions revolutionizing production, management, and delivery with the Next Utility Operating System®, smart microgrids, wireless EV charging, and on-demand mobile fuel, today announced a strategic partnership with Hudson Sustainable Group LLC, one of th ...

Core Viewpoint - Saratoga Investment Corp. has declared a base quarterly dividend of $0.75 per share for the second quarter of fiscal 2026, continuing its strong dividend distribution history and providing a 12.5% dividend yield based on its recent stock price of $24.08 per share [1][2]. Dividend Declaration - The declared dividends for the second quarter of fiscal 2026 are as follows: - June 2025: $0.25 per share, record date July 8, 2025, payment date July 24, 2025 - July 2025: $0.25 per share, record date August 6, 2025, payment date August 21, 2025 - August 2025: $0.25 per share, record date September 4, 2025, payment date September 24, 2025 [1]. Historical Dividend Distributions - The total dividend for fiscal year 2026 is projected to be $1.50 per share, with consistent monthly dividends of $0.25 per share since fiscal Q1 2026 [3]. - Historical dividends per share for previous fiscal years include: - Fiscal 2025: $2.96 total, with quarterly distributions of $0.74 - Fiscal 2024: $2.86 total, with quarterly distributions of $0.71 to $0.73 - Fiscal 2023: $2.44 total, with quarterly distributions ranging from $0.53 to $0.69 [3]. Company Overview - Saratoga Investment is a specialty finance company focused on providing customized financing solutions to U.S. middle-market businesses, primarily through senior and unitranche leveraged loans and mezzanine debt [4]. - The company aims to generate attractive risk-adjusted returns through current income and long-term capital appreciation from its investments [4]. - Saratoga Investment is regulated as a business development company and is externally managed by Saratoga Investment Advisors, LLC [4].

GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announces that its Board of Directors have approved a proposed reverse stock split of its common stock at a ratio of 25-for-1. The proposed action remains subject to approval by Nasdaq and, if approved, the Company ...

Patent portfolio now includes protection for manufacture, methods and compositions Provides AIM with patent protection for manufacturing Ampligen until 2041 OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMID) (“AIM” or the “Company”) today announced the United States Patent and Trademark Office has granted U.S. patent No. 12312376, titled “Therapeutic Double Stranded RNA and Methods for Producing the Same.” The patent expires January 25, 2041. The new pa ...

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain Intelligence Group, is pleased to announce the official launch of AI integration into Intraverse, TerraZero’s immersive social gaming technology platform. This marks the debut of “Gigi”, the platform’s new AI guide, designed to help users explore, interact, and ...

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that members of its executive team will attend the 2025 BIO International Convention, taking place June 16th – 19th in Boston, Massachusetts. Rakovina Therapeutics’ management will participate in one-on-one partnering ...

SINGAPORE, June 12, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that the Company will be participating in an upcoming tech-focused webinar series hosted by Webull on June 20th. Webull Tech Week Corporate Webinar Series Presentation format with Q&A to follow Who: Sebastian Toke, Group CEOWhen: June 20, 2025, 2:00pm – 3:00pm EasternWhere: Virtual - Register Here About GCL Global Holdings GCL Global Hol ...

Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Oncology recentl ...

Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 - $100 million (excluding ACT Genomics)IM8 contributed $5.7 million in Q1, with $2.8 million in March alone & provides Q2 revenue projectionsIM8 has more than 55,000 customers with 4.9 million servings delivered and countingDetails of crypto strategy and Bitcoin adoption to be announced soon as part of innovative treasury approach CHARLOTTE, N.C., June 12, 2025 (GLOBE NEWSWIRE) -- Prenetics G ...

High-purity MREC production: Successfully produced a Mixed-Rare-Earth Carbonate (MREC) product that meets quality specifications for conventional solvent-extraction separation circuitsStrong magnetic rare-earth recoveries: High recoveries of magnetic rare earth elements NdPr and DyTb via hydrometallurgical leaching, with TREO extraction rates between 86-90%Uranium co-product recovery: Successful extraction of uranium with precipitation of uranium peroxide (a form of yellowcake)Direct ‘run-of-mine’ mineral-t ...